Lenz Robert A. bought NBP
August 22, 2026 · Form 4 insider transaction
Lenz Robert A. bought 17,218 shares of NovaBridge Biosciences, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,218
Price
N/A
Total value
N/A
InsiderLenz Robert A.
RoleOfficer, Director
CompanyNovaBridge Biosciences (NBP)
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateAugust 22, 2026
Filing dateAugust 25, 2026
Shares owned after17,218
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.; Reported securities are represented by 7,486 ADSs.; Each restricted stock unit ("RSU") represents a contingent right to receive one ADS.